Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

An update on brain imaging in parkinsonian dementia.

Petrou M, Kotagal V, Bohnen NI.

Imaging Med. 2012 Apr;4(2):201-213.

2.

Morphological substrates of mental dysfunction in Lewy body disease: an update.

Jellinger KA.

J Neural Transm Suppl. 2000;59:185-212.

PMID:
10961431
3.

The cholinergic system and Parkinson disease.

Bohnen NI, Albin RL.

Behav Brain Res. 2011 Aug 10;221(2):564-73. doi: 10.1016/j.bbr.2009.12.048. Epub 2010 Jan 7. Review.

4.

Morphological substrates of dementia in parkinsonism. A critical update.

Jellinger KA.

J Neural Transm Suppl. 1997;51:57-82.

PMID:
9470129
5.

The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.

Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P.

Brain. 2011 Nov;134(Pt 11):3146-66. doi: 10.1093/brain/awr177. Epub 2011 Aug 2. Review.

6.

Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Colosimo C, Hughes AJ, Kilford L, Lees AJ.

J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):852-6.

7.

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, Mathis ChA, Davis JG, Moore RY, Dekosky ST.

J Neurol. 2006 Feb;253(2):242-7. Epub 2005 Sep 2.

PMID:
16133720
8.

[Parkinson syndrome and cognitive disorders].

Szirmai I, Kovács T.

Ideggyogy Sz. 2002 Jul 20;55(7-8):220-5. Review. Hungarian.

PMID:
12201229
9.

Functional brain imaging of cognitive dysfunction in Parkinson's disease.

Hirano S, Shinotoh H, Eidelberg D.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):963-9. doi: 10.1136/jnnp-2011-301818. Epub 2012 Jul 17. Review.

PMID:
22807560
10.

[Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].

Okada J, Peppard R, Calne DB.

Nihon Igaku Hoshasen Gakkai Zasshi. 1989 May 25;49(5):643-56. Japanese.

PMID:
2798056
11.
12.

How to diagnose dementia with Lewy bodies: state of the art.

Geser F, Wenning GK, Poewe W, McKeith I.

Mov Disord. 2005 Aug;20 Suppl 12:S11-20. Review.

PMID:
16092075
13.

Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.

Arnaldi D, Morbelli S, Morrone E, Campus C, Nobili F.

Q J Nucl Med Mol Imaging. 2012 Feb;56(1):55-67. Review.

PMID:
22460160
14.

Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.

Duda JE.

Dement Geriatr Cogn Disord. 2004;17 Suppl 1:3-14. Review.

PMID:
14676464
15.

Imaging: What can it tell us about parkinsonian gait?

Bohnen NI, Jahn K.

Mov Disord. 2013 Sep 15;28(11):1492-500. doi: 10.1002/mds.25534. Review.

16.

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis.

van den Berge SA, Kevenaar JT, Sluijs JA, Hol EM.

Parkinsons Dis. 2012;2012:420957. doi: 10.1155/2012/420957. Epub 2012 Apr 22.

17.

Cholinergic dysfunction in Parkinson's disease.

Müller ML, Bohnen NI.

Curr Neurol Neurosci Rep. 2013 Sep;13(9):377. doi: 10.1007/s11910-013-0377-9. Review.

18.

Dementia in Parkinson's disease: cause and treatment.

Emre M.

Curr Opin Neurol. 2004 Aug;17(4):399-404. Review.

PMID:
15247534
19.

Imaging biomarkers in Parkinson's disease.

Brooks DJ, Pavese N.

Prog Neurobiol. 2011 Dec;95(4):614-28. doi: 10.1016/j.pneurobio.2011.08.009. Epub 2011 Aug 30. Review.

PMID:
21896306
20.

Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.

Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV, et al.

Alzheimer Dis Assoc Disord. 1993 Summer;7(2):69-79.

PMID:
8347330
Items per page

Supplemental Content

Write to the Help Desk